According to the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes. That’s a little more than 11% of the entire population.

A diabetic’s body does not make enough or any insulin at all. Those with the disease must regularly monitor their blood sugar. This has traditionally been done with glucometers, which diabetics use to repeatedly prick their fingers for drops of blood. But over the past decade, technologies like continuous glucose monitoring have been on the rise.

Abbott and Dexcom are the two most dominant players in the space. Both companies have seen increased growth.

The technology is also being marketed by several health and wellness apps as many companies see benefits for those who do not have diabetes.

CNBC spoke with both Abbott and Dexcom about the technology in continuous glucose monitors and how they see it expanding.

Watch the video to learn more.